KA! Empathogenics Competitors

We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing. We’re driven by our purpose of unlocking pathways to be—opening futures filled with possibility. Together, we’re on an ambitious journey toward enabling people living with mental health conditions to find clarity through self-discovery. Every journey needs a Compass.

MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!

We are scientists, researchers, healthcare clinicians, and digital and gaming experts who are passionate about creating new approaches to help people improve their mental health & well-being and become more resilient. With a deep understanding of digital consumer behavior built through years of testing and optimization with 3.5 million users, we’ve designed a global, digital platform, grounded in science, that delivers a dynamic user experience so delightful that building healthier habits feels effortless. Happify Health makes managing mental health & well-being not just possible, but fun.